TLSA: Tiziana Life Sciences Ltd Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 51.27
Enterprise Value ($M) 51.27
Book Value ($M) 0.00
Book Value / Share 0.00
Price / Book n/a
NCAV ($M) 0.00
NCAV / Share 0.00
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) n/a
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio n/a
Current Ratio n/a

Balance Sheet (mrq) ($M)
Current Assets 0.00
Assets 0.00
Liabilities 0.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-02-23 4,072 22,115 18.41
2024-02-22 5,069 66,227 7.65
2024-02-21 6,621 30,010 22.06
2024-02-20 766 18,105 4.23

(click for more detail)

Similar Companies
THAR – Tharimmune, Inc. THTX – Theratechnologies Inc.
TIL – Instil Bio, Inc. TNXP – Tonix Pharmaceuticals Holding Corp.
TPST – Tempest Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io